FIELD: organic chemistry, peptides, amino acids, medicine, endocrinology. SUBSTANCE: invention relates to compounds of the formula: 
where A7-A37 represent different amino acid residues and radical values given in claim 1 of the invention. Compounds are peptide analogues of glucagons-like peptide-1 (GLP-1) and can be used in treatment of patients with such diseases as diabetes mellitus and obesity and other diseases associated with GLP-1 also. Invention describes also pharmaceutical compositions comprising compounds given in the invention. EFFECT: valuable medicinal properties of compounds. 9 cl, 103 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SOMATOSTATIN RECEPTOR ANTAGONISTS | 1997 |
|
RU2179172C2 |
| GLP-1 ANALOGS | 1999 |
|
RU2288232C9 |
| UROTENSIN-II AGONISTS AND ANTAGONISTS | 2001 |
|
RU2263679C2 |
| MELANOCORTIN RECEPTOR LIGANDS | 2006 |
|
RU2439079C2 |
| MELANOCORTIN RECEPTOR LIGANDS | 2006 |
|
RU2380372C2 |
| GRELIN ANALOGS | 2003 |
|
RU2315059C2 |
| NEUROMEDIN AND SOMATOSTATIN RECEPTOR AGONISTS | 2000 |
|
RU2263680C2 |
| GHRELIN ANALOGUES | 2003 |
|
RU2373220C2 |
| PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACIDS OR SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO BOMBESINE, METHOD OF TREATMENT OF MAMMALIAN WITH CANCER | 1994 |
|
RU2114118C1 |
| SOMATOSTATIN AGONISTS | 2002 |
|
RU2259375C2 |
